The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
抗PD-L1/CTLA-4双特异性抗体KN046联合乐伐替尼治疗晚期不可切除或转移性肝细胞癌:一项II期临床试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-56537-y
Xu, Da; Wang, Hongwei; Bao, Quan; Jin, Kemin; Liu, Ming; Liu, Wei; Yan, Xiaoluan; Wang, Lijun; Zhang, Yanqiao; Wang, Guangyu; Ma, Yue; Ma, Zhigang; Zhang, Chunhui; Tang, Jiebing; Wang, Sha; Pang, Jiaohui; Xu, Ting; Wang, Kun; Xing, Baocai